SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-214074
Filing Date
2020-08-10
Accepted
2020-08-10 07:10:52
Documents
3
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940421d8k.htm 8-K 19452
2 EX-99.1 d940421dex991.htm EX-99.1 59261
3 EX-99.2 d940421dex992.htm EX-99.2 13997
  Complete submission text file 0001193125-20-214074.txt   93902
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 201087052
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences